teva pharmaceuticals introduces the first generic glp-1 for weight loss Saxenda First Generic GLP-1 Injection OK'd

Further in vitro studies in IEC-6 cells revealed that exendin-4 enhanced SERT expression and increased 5-HT reuptake [58] (Fig

"Sometimes these knockoff medicines which come from places like China and India are sold by entities that cannot even legally sell them in their own countries," said Patrik Jonsson, president of Lily USA.

However, an effort to change this and allow Medicare to cover obesity medications is within the Federal Treat and Reduce Obesity Act legislation (see sidebar Resources).1 Reference 1

Slower titration in Phase 3 trials is expected to improve tolerability

doi: 10.1016/j.rec.2025.02.006 76 RangaswamiJBhallaVde BoerIHStaruschenkoASharpJASinghRRet al

Learn More Now: The Body Insight Method